Knee injection for osteoarthritis pain
Part of Bones, joints & muscles clinical trials.
This trial tests a new knee injection called MAG200. It may reduce knee pain and make daily activities easier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 35 and 75 years old
- You have been diagnosed with knee osteoarthritis (mild to moderate, not the most severe)
- You have moderate to severe knee pain, especially when moving
- You have tried treatments like pain medication or physical therapy in the last 12 months
- You have not had knee surgery or a major knee injury in the past year
- You can have an MRI of your knee
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests an injection of donor stem cells placed into the knee joint to help reduce symptoms of knee osteoarthritis. You may be eligible if you have long-lasting knee pain from mild-to-moderate arthritis and meet safety and imaging requirements.
This study tests a new stem cell treatment for knee osteoarthritis. It aims to see if injecting these cells into the knee can reduce pain and improve function compared to other treatments.
This trial tests a new treatment using donor stem cells injected into the knee for people with moderate knee osteoarthritis. It aims to see if these cells can reduce pain and improve function.
This study tests a new treatment made from umbilical cord cells (stem cells) that are injected into the knee. It aims to see if this injection can safely reduce pain and improve function for people with knee osteoarthritis.
This Phase 2 study tests whether injected umbilical-cord stem cells can improve safety and reduce symptoms in people with moderate knee osteoarthritis. It focuses on people with significant knee pain who have not gotten enough relief from standard, non-procedure treatments.
This study tests an experimental injection called GNSC-001 given directly into the knee to see if it can reduce pain and improve knee function in people with knee osteoarthritis. If you join, you'll have one injection and then be followed for a year, and you'll need to stop your usual knee pain medicines during the study.
Hear when a new Knee Osteoarthristis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.